Cargando…

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

PURPOSE: Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis. METHODS: Eligible...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hubner, Richard A., Riley, Richard D., Billingham, Lucinda J., Popat, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194810/ https://www.ncbi.nlm.nih.gov/pubmed/22022380 http://dx.doi.org/10.1371/journal.pone.0025164

Ejemplares similares

Problems of variable biomarker evaluation in stratified medicine research—A case study of ERCC1 in non-small-cell lung cancer
por: Malottki, Kinga, et al.
Publicado: (2016)

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
por: Rao, Devika, et al.
Publicado: (2019)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
por: Peng, Haiying, et al.
Publicado: (2018)

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis
por: Yang, Yanlong, et al.
Publicado: (2014)

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
por: Matsubara, J, et al.
Publicado: (2008)

Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer
por: Joo, Jungnam, et al.
Publicado: (2016)

XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways
por: Mulderrig, Lee, et al.
Publicado: (2020)

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
por: Sreekumar, Rahul, et al.
Publicado: (2021)

Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1
por: Yang, Lanlan, et al.
Publicado: (2017)

The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients
por: Chitapanarux, Imjai, et al.
Publicado: (2020)

X-Ray Repair Cross Complementing Protein 1 in Base Excision Repair
por: Hanssen-Bauer, Audun, et al.
Publicado: (2012)

Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk
por: Tsai, Chia-Wen, et al.
Publicado: (2018)

Germline ERCC excision repair 6 like 2 ( ERCC6L2 ) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
por: Armes, Hannah, et al.
Publicado: (2022)

XPF–ERCC1: Linchpin of DNA crosslink repair
por: McHugh, Peter J.
Publicado: (2020)

Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
por: Li, Mu-Xing, et al.
Publicado: (2016)

Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
por: SONG, PENG, et al.
Publicado: (2015)

Deletion of the Nucleotide Excision Repair Gene Ercc1 Reduces Immunoglobulin Class Switching and Alters Mutations Near Switch Recombination Junctions
por: Schrader, Carol E., et al.
Publicado: (2004)

Complementation of aprataxin deficiency by base excision repair enzymes
por: Çağlayan, Melike, et al.
Publicado: (2015)

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer
por: Aiello, Marco Maria, et al.
Publicado: (2020)

Novel germline ERCC5 mutations identified in a xeroderma pigmentosum complementation group G pedigree
por: Wang, Tao, et al.
Publicado: (2015)

Reviewing the evidence supporting predictive biomarkers in European medicines agency indications and contraindications using visual plots
por: Malottki, Kinga, et al.
Publicado: (2015)

Challenges in the development of prognostic models utilising clinical trials data
por: Snell, Kym, et al.
Publicado: (2013)

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

Deficiency in Nucleotide Excision Repair Family Gene Activity, Especially ERCC3, Is Associated with Non-Pigmented Hair Fiber Growth
por: Yu, Mei, et al.
Publicado: (2012)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts
por: Çağlayan, Melike, et al.
Publicado: (2017)

Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study
por: Kulkarni, Spoorti, et al.
Publicado: (2020)

Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
por: Tang, Yunxiang, et al.
Publicado: (2021)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
por: Mountzios, Giannis, et al.
Publicado: (2008)

Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice
por: de Waard, Monique C., et al.
Publicado: (2010)

Precise Localization of the Excision Repair Gene, ERCC5, to Human Chromosome 13q32.3‐q33.1 by Direct R‐Banding Fluorescence in situ Hybridization
por: Takahashi, Ei‐ichi, et al.
Publicado: (1992)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso
por: Adico, Marc Donald Wilfried, et al.
Publicado: (2023)

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A
por: Wang, Xiaozhu, et al.
Publicado: (2017)

Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_27enhlvdbs7r3h4bl4dfp241cm